The use of skin whitening pills including glutathione, amino acids, vitamins, flavonoids, and carotenoids, in treating some types of metabolically induced skin hyperpigmentation is supported by research
Aspirin use and PI3K mutations in metastatic colorectal cancer (mCRC)
Trigger points are involuntary tight tender spots in a contracted muscle
7 February 2023 by Andrew Anton Mako and Stephen Howes 17 January 2023 by Andrew Anton Mako 23 November 2022 by Terence Wood 18 March 2022 by Lydia Papandrea 21 December 2021 by Maholopa Laveil 6 September 2021 by Maholopa Laveil and Michael Kabuni 8 July 2021 by Maholopa Laveil 22 September 2020 by Fredrick Guande 27 March 2017 by Rohan Fox and Stephen Howes 10 November 2016 by Stephen Howes 12 September 2016 by Stephen Howes and Rohan Fox
Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide
CJC-1295 stimulates sustained GH release , while Ipamorelin triggers short, natural pulses of GH
